Wednesday December 2, 2020 00:18

Heathcare Press Release : 07 Oct 2020

Merck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Heathcare—07 Oct 20

- Anti-ADAMTS5 Nanobody(R) program is Phase II-ready with novel MoA which could protect against cartilage damage and reduce joint pain - Merck receives upfront payment of EUR 50 million with the potential of receiving a further EUR 400 million related

Medicom Announces New USA Mask Manufacturing Plant Heathcare—07 Oct 20

The Medicom Group ("Medicom"), one of the world's leading manufacturers of surgical and respiratory masks, today announced the expansion of its U.S. mask manufacturing operations. The company will be adding a second factory with triple the square footage